Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
drug prices
6
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
deals
startups
cancer
generic drugs
medicare
alzheimer's disease
biogen
bristol-myers squibb
cancer immunotherapy
clinical trials
eli lilly
gene therapy
What
bio
6
×
roundup
drug
approval
companies
drugs
gene
pharmaceutical
price
acquisitions
advanced
ahead
albert
alnylam’s
alzheimer’s
appetite
asco
bff
biggest
biogen’s
biopharmaceutical
black
bourla
branded
bread
butter
buyout
cancer
cash
ceo
choices
commissioner
company
conference
consumers
convo
costly
counterweight
crispr
deals
Language
unknown
Current search:
bio
×
" drug prices "
×
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
